Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration ...

ROSA ® Knee with OptimiZe Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1 WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer ...

As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most ...